Intrathecal delivery of adipose-derived mesenchymal stem cells in traumatic spinal cord injury: Phase I trial

Intrathecal delivery of adipose-derived mesenchymal stem cells in traumatic spinal cord injury: Phase I trial

Abstract Intrathecal delivery of autologous culture-expanded adipose tissue-derived mesenchymal stem cells (AD-MSC) could be utilized to treat traumatic spinal cord injury (SCI). This Phase I trial (ClinicalTrials.gov: NCT03308565) included 10 patients with American Spinal Injury Association Impairm...

Full description

Bibliographic Details
Main Authors: Mohamad Bydon, Wenchun Qu, F. M. Moinuddin, Christine L. Hunt, Kristin L. Garlanger, Ronald K. Reeves, Anthony J. Windebank, Kristin D. Zhao, Ryan Jarrah, Brandon C. Trammell, Sally El Sammak, Giorgos D. Michalopoulos, Konstantinos Katsos, Stephen P. Graepel, Kimberly L. Seidel-Miller, Lisa A. Beck, Ruple S. Laughlin, Allan B. Dietz
Format: Article
Language:English
Published: Nature Portfolio 2024-04-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-024-46259-y

Internet

https://doi.org/10.1038/s41467-024-46259-y

Similar Items